Navigation Links
Simcere Pharmaceutical Group to Announce First Quarter 2013 Financial Results on Thursday, May 9, 2013
Date:4/26/2013

NANJING, China, April 26, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2013 on Thursday, May 9, 2013, before the market opens in the United States. Simcere's management will host an earnings conference call on the same day at 8 a.m. ET (Thursday, May 9, at 8 p.m. Beijing/Hong Kong time).

To access the conference call, please dial:International toll: 

+65.6723.9381United States toll-free: 

+1.866.519.4004United States toll: 

+1.718.354.1231China Domestic toll: 

800.819.0121 China Domestic mobile toll: 

400.620.8038 Hong Kong toll: 

+852.2475.0994Please ask to be connected to Q1 2013 Simcere Pharmaceutical Group Earnings Conference Call and provide the following passcode: 58031483.

Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's web site at www.simcere.com.

Following the earnings conference call, an archive of the call will be available by dialing:United States toll-free:

+1. 855.452.5696United States toll:

+1. 646.254.3697The passcode for replay participants is 58031483. The telephone replay also will be archived on the "Investor Relations" section of the company's website for seven days following the earnings announcement.

About Simcere Pharmaceutical GroupSimcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, cardiovascular disease, infectious diseases and pain. For more information about Simcere Pharmaceutical Group, please visit www.simcere.com.Investor and Media Contacts: Email: ir@simcere.com In Nanjing:Jie Liu D'EliaVice PresidentSimcere Pharmaceutical GroupTel: 86-25-8556-6666*8857In the United States:Cindy Zheng

Brunswick Group

Tel: 1-212-333-3810In Beijing: Yue YuBrunswick GroupTel: 86-10-5960-8 

 

 


'/>"/>
SOURCE Simcere Pharmaceutical Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Financial Advisor
2. Simcere Pharmaceutical Group Announces Issuance of GMP Certificate to Simcere Vaxtec
3. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Legal Counsel
4. Simcere Pharmaceutical Group Announces Receipt of "Going Private" Proposal
5. Simcere Pharmaceutical Group Reports Preliminary Unaudited Fourth Quarter And Full Year 2012 Results
6. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on Thursday, March 7, 2013
7. Simcere Pharmaceutical Group Announces Sale of Equity Interest in Shanghai Celgen
8. Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2012 Results
9. Simcere Pharmaceutical Group to Announce Third Quarter 2012 Financial Results on Thursday, November 15, 2012
10. Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer
11. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... DUBLIN , April 28, 2016 ... the "Global Plastic Surgery Products Market 2016-2020" ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , The global plastic ... CAGR of 9.47% during the period 2016-2020. , ,The ... factor leading to the growth of the market. Lasers ...
(Date:4/28/2016)... -- The blood testing market in China ... and The Freedonia Group in a recent report.  The ... healthcare research firm said that China ... and in improving testing at the provincial level.   The ... Blood Testing Market in China , which utilized ...
(Date:4/28/2016)... April 28, 2016 Dr. Vivek ... and Ste phen Schmidt ... a leading provider of cloud-based software solutions for life sciences, today ... to bring a wealth of insight to a growing business.  This ... George Phillips joined ArisGlobal in the position ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is ... treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients ... or both jaw bones. This surgery is performed to correct the alignment of the jaw. ...
(Date:4/29/2016)... GA (PRWEB) , ... April 29, 2016 , ... ... the closing of a growth round of funding led by Eastside Partners, with ... support the company’s rapidly growing customer base and accelerate its technology and product ...
(Date:4/29/2016)... ... 2016 , ... CURE Media Group , the nation’s ... today announced that Lynne Malestic, RN, of Eisenhower Lucy Curci Cancer Center in ... Oncology Nursing , which honors nurses who have dedicated their careers to helping ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... to promote their animal line of probiotics, Petbiotics ™, as they fondly ... turnout of animal rescue groups networking for their non-profit organizations. Animal rescues across ...
(Date:4/29/2016)... ... 29, 2016 , ... Coalition Duchenne, a Newport Beach, California ... Duchenne research, participated in the April 25 U.S. Food and Drug Administration advisory ... The meeting at the Marriott Conference Center in Hyattsville, Maryland was attended by ...
Breaking Medicine News(10 mins):